Applied Biophysics for Drug Discovery

  • ID: 4076982
  • Book
  • 312 Pages
  • John Wiley and Sons Ltd
1 of 4

Applied Biophysics for Drug Discovery is a guide to new techniques and approaches to identifying and characterizing small molecules in early drug discovery. Biophysical methods are reasserting their utility in drug discovery and through a combination of the rise of fragment–based drug discovery and an increased focus on more nuanced characterisation of small molecule binding, these methods are playing an increasing role in discovery campaigns.

This text emphasizes practical considerations for selecting and deploying core biophysical method, including but not limited to ITC, SPR, and both ligand–detected and protein–detected NMR.

Topics covered include:

  • Design considerations in biophysical–based lead screening
  • Thermodynamic characterization of protein–compound interactions
  • Characterizing targets and screening reagents with HDX–MS
  • Microscale Thermophoresis methods (MST)
  • Screening with Weak Affinity Chromatography
  • Methods to assess compound residence time
  • 1D–NMR methods for hit identification
  • Protein–based NMR methods for SAR development
  • Industry case studies integrating multiple biophysical methods

This text is ideal for academic investigators and industry scientists planning hit characterization campaigns or designing and optimizing screening strategies.

Note: Product cover images may vary from those shown
2 of 4

List of Contributors

1. IntroductionDonald Huddler

2. Thermodynamics in Drug DiscoveryOBrienMarkova&Holdgate

3. Tailoring Hit Identification and Qualification Methods for Targeting Protein–Protein InteractionsBjörn Walse, Andrew P. Turnbull, Susan M. Boyd

4. HYDROGEN DEUTERIUM EXCHANGE MASS SPECTROMETRY IN DRUG DISCOVERYThorleif Lavold, Roman Zubarev and Juan Astorga–Wells

5. MICROSCALE THERMOPHORESIS IN DRUG DISCOVERYTanja Bartoschik, Melanie Maschberger, Alessandra Feoli, Timon André, Philipp Baaske, Stefan Duhr and Dennis Breitsprecher

6. SPR Screening Applying the new generation of SPR hardwareKartik Narayan and Steve Carroll

7. Weak Affinity Chromatography (WAC)Sten Ohlson∗ and Minh–Dao Duong–Thi

8. 1D NMR Methods for Hit IdentificationMary J Harner, Guille Metzler, Caroline A Fanslau, Luciano Mueller, William J Metzler

9. Protein–Based NMR Methods Applied to Drug DiscoveryAlessio Bortoluzzi, Alessio Ciulli

10. Applications of Ligand and Protein–observed NMR in DiscoveryIsabelle Krimm

Conclusion

11. Using Biophysical Methods to Optimize Compound Residence TimeG. A. Holdgate, P. Rawlins, M. Bista, C. J. Stubbs

12. Applying biophysical and biochemical methods to the discovery of allosteric modulators of the AAA ATPase p97Stacie L. Bulfer and Michelle R. Arkin

13. Driving Drug Discovery with Biophysical Information Application to Staphylococcus aureus Dihydrofolate Reductase (DHFR)Parag Sahasrabudhe, Veerabahu Shanmugasundaram, Mark Flanagan, Kris A. Borzilleri, Holly Heaslet, Anil Rane, Alex McColl, Tim Subashi, George Karam, Ron Sarver, Melissa Harris, Boris A. Chrunyk, Chakrapani Subramanyam, Thomas V. Magee, Kelly Fahnoe, Brian Lacey, Henry Putz, J. Richard Miller, Jaehyun Cho, Arthur Palmer III and Jane M. Withka

14. Assembly of fragment screening libraries: Property and diversity analysisBradley C. Doak, Craig J. Morton, Jamie S. Simpson & Martin J. Scanlon

Index

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

Donald Huddler, Widener University Delaware Law School, Wilmington, USA.

Edward R. Zartler is Chief Scientific Officer at Quantum Tessera Consulting, LLC, USA.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll